Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-05-036644
Filing Date
2005-07-12
Accepted
2005-07-12 10:08:53
Documents
2
Period of Report
2002-09-25

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION b55794ra3.html 3  
1 MAIN DOCUMENT DESCRIPTION b55794ra3.xml 3 5823
2 ADDITIONAL EXHIBITS exhibit99form3.txt EX-99 634
  Complete submission text file 0001209191-05-036644.txt   9389
Mailing Address 14 CAMBRIDGE CTR CAMBRIDGE MA 02142
Business Address 14 CAMBRIDGE CTR CAMBRIDGE MA 02142 617-679-2000
BIOGEN IDEC MA INC (Reporting) CIK: 0000714655 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-23930 | Film No.: 05949482
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 11011 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11011 TORREYANA ROAD SAN DIEGO CA 92121 6195508500
BIOGEN IDEC INC (Reporting) CIK: 0000875045 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-23930 | Film No.: 05949481
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101
Business Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101 2066237612
TARGETED GENETICS CORP /WA/ (Issuer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)